Biological approaches to human cancer virus detection.

Biological approaches to human cancer virus detection. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Biological approaches to human cancer virus detection. Abstract Text:

Biological approaches to human cancer virus detection. Publishing Authors By Initials

For similar virus diseases: tumor virus infections research abstracts see: virus diseases: tumor virus infections research

PUBMED ID PMID:

MEDLINE DATE:

Biological approaches to human cancer virus detection. Journal Published:

PUBLICATION TYPE: Review

Journal: Progress in experimental tumor research. Fortschri

VOLUME: 21

Page Numbers: 2-18

Journal Abbreviation:

ISSN: 0079-6263

DAY: 25

MONTH: 02

YEAR: 1978

Biological approaches to human cancer virus detection. Information

Number of References: 77

LANGUAGE: eng

NlmUniqueID: 376446

Biological approaches to human cancer virus detection. Keywords Mesh Terms:

KEYWORDS: Tumor Virus Infections

MESH TERMS: microbiology

Chemical & Substance for Abstract: Biological approaches to human cancer virus detection. Information

Substance Name: Antigens, Viral

Registry Number: 0

Grant and Affiliation Information for Biological approaches to human cancer virus detection.

AFFILIATION:

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Prog Exp Tumor Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Biological approaches to human cancer virus detection Related Publications

• APPL1 associates with TrkA and GIPC1 and is required for nerve growth factor-mediated signal transduction.
• AUA Guidelines and Their Impact on the Management of BPH: An Update.
• Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus.
• Acute lymphocytic infiltration in an extremely early lesion of fibrodysplasia ossificans progressiva.
• Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells.
• Bruton's tyrosine kinase is required for TLR-induced IL-10 production.
• Complications of anterior skull base surgery.
• Dose-dependent immune response to Mycobacterium bovis BCG vaccination in neonates.
• Embryonic overexpression of the c-Fos protooncogene. A murine stem cell chimera applicable to the study of fibrodysplasia ossificans progressiva in humans.
• Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds.
• Evidence for the multimeric structure of ferroportin.
• Expanding the role of photoselective vaporization of the prostate.
• Exploratory evaluation of several teratogen warning symbols.
• Extracellular matrix remodeling--methods to quantify cell-matrix interactions.
• Factors in Predicting Failure with Medical Therapy for BPH.
• Ferroportin-mediated mobilization of ferritin iron precedes ferritin degradation by the proteasome.
• Genome analyses of three strains of Rhodobacter sphaeroides: evidence of rapid evolution of chromosome II.
• Impact of inflammation on ocular immune privilege.
• Laser prostatectomy: checkup on the promises.
• Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
• Medical therapy for benign prostatic hyperplasia: new terminology, new concepts, better choices.
• Mycobacterium leprae inhibits dendritic cell activation and maturation.
• RGD-functionalized bioengineered spider dragline silk biomaterial.
• Sgt1p is a unique co-chaperone that acts as a client adaptor to link Hsp90 to Skp1p.
• Socioeconomic and psychosocial exposures across the life course and binge drinking in adulthood: population-based study.
• Temperament characteristics of street and non-street children in Eldoret, Kenya.
• The mitochondrial citrate transport protein: evidence for a steric interaction between glutamine 182 and leucine 120 and its relationship to the substrate translocation pathway and identification of other mechanistically essential residues.
• The use of botulinum toxin in men with benign prostatic hyperplasia.
• Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.
• alpha-Blocker Therapy: Current Update.